APA (7th ed.) Citation

N, N., H, N., K, Y., A, N., & R, O. (2025). A case of hepatitis B virus reactivation after elranatamab therapy in a patient with multiple myeloma. Journal of pharmaceutical health care and sciences, 11(1), 91. https://doi.org/10.1186/s40780-025-00506-6

Chicago Style (17th ed.) Citation

N, Nishimura, Nakashima H, Yoshikuni K, Numata A, and Ogawa R. "A Case of Hepatitis B Virus Reactivation After Elranatamab Therapy in a Patient with Multiple Myeloma." Journal of Pharmaceutical Health Care and Sciences 11, no. 1 (2025): 91. https://doi.org/10.1186/s40780-025-00506-6.

MLA (9th ed.) Citation

N, Nishimura, et al. "A Case of Hepatitis B Virus Reactivation After Elranatamab Therapy in a Patient with Multiple Myeloma." Journal of Pharmaceutical Health Care and Sciences, vol. 11, no. 1, 2025, p. 91, https://doi.org/10.1186/s40780-025-00506-6.